PDCD1LG2 and Miyoshi myopathy: We validated here that several immune checkpoint ligands, including GAL9, ICOSL, HLA‐DR, CD86, PD‐L2 and 4‐1BBL, were more generally presented on MM cells and these ligands are able to largely influence the immune response through binding to their receptors on immune effector cells.